Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound

Canada News News

Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Canada Latest News,Canada Headlines
  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Insatiable demand for weight-loss drugs has made the market so feverish that any positive mention of a potential obesity therapy can send a company’s stock surging — even if those treatments may still be years away.

Apple Rallies After Company Forecasts Return to Sales GrowthBofA Hires Goldman Sachs, Deutsche Bank Traders in Europe PushAmgen Soars After CEO Gives Update on Experimental Obesity DrugTodd Boehly’s Eldridge Acre Seeks to Bet $3 Billion on US Real EstateGold Heads for Worst Weekly Run Since February on Rate OutlookGlencore-Backed Group Said Near Deal for Shell Singapore AssetsTD Risks an Earnings Hit From US Laundering Probe, Analysts SayVanguard Urges Investors ‘Right-Size’ Toward Bonds on Fed...

22%Blackstone Taps Vast Source of Cash in $1 Trillion Credit PushMercadoLibre Weathers Argentina Tumult With Mexico, Brazil GainsApple Rallies After Company Forecasts Return to Sales GrowthEverything Apple Plans to Show at May 7 ‘Let Loose’ iPad EventBofA Hires Goldman Sachs, Deutsche Bank Traders in Europe PushIsrael-Hamas War Boosts Profile of Erdogan Opponent in TurkeyHouthis Threaten to Try to Attack Ships in Mediterranean SeaFood Critic Keith Lee Is Saving Struggling Restaurants One TikTok...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BNNBloomberg /  🏆 83. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lilly’s $2.5 Billion German Plant Will Boost Obesity-Drug SupplyLilly’s $2.5 Billion German Plant Will Boost Obesity-Drug SupplyEli Lilly & Co. kicked off construction of a plant to boost the production of its wildly popular weight-loss drugs, which have yet to gain a foothold in Europe.
Read more »

Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityWeight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Read more »

Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityWeight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Read more »

Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityWeight-loss drug Wegovy available in Canada starting May 6 for people with obesityObesity Canada will update its medication guidelines to include Wegovy, which is meant to be used in tandem with physical activity and nutrition
Read more »

Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityWeight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Read more »

Weight-loss drug Wegovy available in Canada starting May 6 for people with obesityWeight-loss drug Wegovy available in Canada starting May 6 for people with obesityThe weight-loss drug Wegovy, made by the manufacturers of Ozempic, will be available to patients in Canada starting Monday, the company says. Novo Nordisk's weekly injection is approved for weight loss among patients diagnosed with obesity.
Read more »



Render Time: 2025-02-16 10:52:12